rx Only
ndc"> rx Only
ndc" />

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Methylprednisolone Sodium Succinate is a . Marketed by rx Only
ndc 71329-303-01
methylprednisolone Sodium Succinate For Injection, Usp
500 Mg Multi-dose Vial
for Intramuscular Or Intravenous Use

Identification & Billing

NDC Package Code
71329-305-01
Package Description
30.6 mL in 1 VIAL
Product Code
11-Digit Billing Format
71329030501

Clinical Specifications

Proprietary Name
Methylprednisolone Sodium Succinate
Dosage Form
-

Regulatory & Marketing

Labeler Name
rx Only
ndc 71329-303-01
methylprednisolone Sodium Succinate For Injection, Usp
500 Mg Multi-dose Vial
for Intramuscular Or Intravenous Use
FDA Application #
ANDA212396
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-20-2021
End Marketing Date
03-02-2026
Listing Expiration
03-02-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71329-305-01 identifies a specific commercial package of 30.6 ml in 1 vial of Methylprednisolone Sodium Succinate, labeled by rx Only
ndc 71329-303-01
methylprednisolone Sodium Succinate For Injection, Usp
500 Mg Multi-dose Vial
for Intramuscular Or Intravenous Use

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by rx Only
ndc 71329-303-01
methylprednisolone Sodium Succinate For Injection, Usp
500 Mg Multi-dose Vial
for Intramuscular Or Intravenous Use

How is this rx Only
ndc 71329-303-01
methylprednisolone Sodium Succinate For Injection, Usp
500 Mg Multi-dose Vial
for Intramuscular Or Intravenous Use

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71329030501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
71329-305-01
11-Digit CMS (5-4-2)
71329-0305-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.

Page Last Updated: July 07, 2026
About Us | What is NDC? | Contact Us
Terms of Service | Privacy
NDC List 2026 - The complete repository of National Drug Codes Information

DISCLAIMER:
All contents of this website are provided on an "as is" and "as available" basis without warranty of any kind. While we strive to ensure that the information presented is accurate, up-to-date, and complete, we cannot guarantee or warrant its absolute correctness or timeliness. The contents of the National Drug Codes List website are provided for educational purposes only and are not intended in any way as medical advice, medical diagnosis, or treatment. Reliance on any information provided by the National Drug Codes List website or other visitors to this website is solely at your own risk. We do not warrant that the information on this site will meet your health-related requirements or that it is complete, timely, or suitable for your personal or professional circumstances.
By accessing or using this website, you agree to be bound by these Terms of Service. If you do not agree with any part of these terms, please do not use this site. We reserve the right to update or modify this Disclaimer or our Terms of Service at any time without prior notice. Your continued use of this site following any such changes signifies your acceptance of the revised terms.
This site is not affiliated, endorsed, or administered by the Food and Drug Administration (FDA). Many Over-the-Counter drugs are not reviewed by the FDA but may be marketed to the public if the product complies with applicable rules and regulations. The information on this website is intended for healthcare providers and consumers in the United States. The absence of a warning or notice for a given drug or drug combination does not indicate that the drug or drug combination is safe, appropriate, or effective for any given patient. If you have questions or concerns about the substances you are taking, please consult your healthcare provider.
If you think you may have a medical emergency, call your doctor or dial 911 immediately.